Key result
Higher mean platelet volume correlates strongly with increased platelet CD42a expression in dyslipidemic men.
Why the study?
Platelet function, platelet volume indices, lipid metabolism markers, inflammatory markers, and cyclophilin A (CyPA) are implicated in the pathogenesis of atherosclerosis. This study evaluated the interrelations among these factors, the correlation between platelet function and inflammatory factors, and the function of CyPA.
Cross-Sectional (n=160)
No
In men with dyslipidemia and metabolic syndrome, an increasing number of cardiovascular risk factors is associated with significant elevations in inflammatory and platelet activation biomarkers.
MPV may mark platelet glycoprotein changes in dyslipidemic men; hypothesis-generating and requires prospective validation before clinical use.
Introduction. Platelet function, platelet volume indices, traditional markers of lipid metabolism, inflammatory markers and a novel biomarker, cyclophilin A (CyPA), are related as far as they have implications in pathogenesis of atherosclerosis. The purpose of this study was to evaluate interrelations among these factors, correlation between platelet function and inflammatory factors, also a function of CyPA. Materials and methods. 160 male patients with high risk of atherosclerosis and metabolic syndrome were included in the study. Inclusion criteria were as follows: disturbances in lipids profile, increased weight, smoking, acute or chronic stress, no previous or current acute cardiovascular disease (CVD), high risk and presence of stress confirmed by physician. CRP, vWF, fibrinogen, CyPA levels were measured. Platelet function was assessed by aggregation and flow cytometry. Results. Increasing number of risk factors gave statistically significant elevation in fibrinogen, thrombin receptors activating peptide, CRP, glucose, mean platelet volume (MPV), platelet large cell ratio, lipids and their ratios with extremely significant linearity. MPV correlated positively with CD42a (r = 0.605; p < 0.001) and negatively with CD42a/CD14 (r = –0.327; p < 0.001). Lipid ratios were found to be prognostic for metabolic syndrome biochemical markers. Platelet function parameters showed relation with lipid ratios, lipid-CRP ratios, MPV and vWF. CyPA correlated with CD42a/CD14 (r = 0.202, p = 0.010). Conclusions. Platelets in men with dyslipidemia and other investigated risk factors have a tendency to be hyperreactive. It might be considered as a separate risk factor for CVD. Inflammatory status does not correlate with the platelet function. CyPA reflects inflammatory processes but not the platelet function.
No takes yet. Share an insight, caveat, or question.
Banys et al. (2015) conducted a cross-sectional in Dyslipidemia and high risk of atherosclerosis and metabolic syndrome (n=160). Cardiovascular risk factors and dyslipidemia vs. Reference laboratory values / fewer risk factors was evaluated on Correlation between mean platelet volume (MPV) and CD42a expression (r = 0.605, p=<0.001). Mean platelet volume correlated positively with platelet glycoprotein IX (CD42a) expression (r = 0.605, p < 0.001) and negatively with CD42a/CD14 (r = -0.327, p < 0.001) in men with dyslipidemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: